Siemion et al., 1998 - Google Patents
Peptides related to FKBP 39–45 loop possess immunostimulative potencySiemion et al., 1998
- Document ID
- 3574701969500621618
- Author
- Siemion I
- Strug I
- Wieczorek Z
- Publication year
- Publication venue
- Peptides
External Links
Snippet
151 Taking into account the sequential homology existing between thymopoietin II, the DNA- binding domain of p53 protein and FKBP (FK-506 binding protein), a series of fragments of human and bovine FKBP containing a fragment Ser39-Pro45 were synthesized. In the …
- 102000004196 processed proteins & peptides 0 title abstract description 69
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koletsky et al. | Cyclophilin: distribution and variant properties in normal and neoplastic tissues. | |
KR101484590B1 (en) | Immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections | |
US6265535B1 (en) | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses | |
US6291247B1 (en) | Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity | |
EP1793856A2 (en) | Methods and compositions for treating allergic inflammation | |
KR20020062956A (en) | Depsipeptide and congeners thereof for use as immunosuppressants | |
PT87763B (en) | PROCESS FOR THE PREPARATION OF CICLIC PEPTIOLIDES | |
Kupper et al. | Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2. | |
CA2155103A1 (en) | Tnf-alpha muteins and a process for preparing them | |
AU694602B2 (en) | Novel peptide | |
WO1997015593A1 (en) | Neurotrophin antagonists | |
Cacalano et al. | Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. | |
Deigin et al. | Reciprocal effect of optical isomerism of EW-dipeptides on immune response | |
Cebrat et al. | Immunosuppressive activity of hymenistatin I | |
KR20110093899A (en) | Tumor Necrosis Factor Alpha Inhibitory Peptides and Uses thereof | |
KR101310511B1 (en) | A thymus-specific protein | |
Siemion et al. | Peptides related to FKBP 39–45 loop possess immunostimulative potency | |
Conlon et al. | An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina | |
NO149631B (en) | ANALOGY PROCEDURE FOR PREPARING BIOLOGICALLY ACTIVE POLYPEPTIDES | |
WO1993025580A1 (en) | Cyclic peptides that modulate endothelin activity | |
Reem | Molecular mode of action of cyclosporin and FK506in human thymocytes | |
Pasikowski et al. | A novel immunosuppressory peptide originating from the ubiquitin sequence | |
Dardenne et al. | Stimulatory effects of cyclosporin A on human and mouse thymic epithelial cells | |
EP2706113A1 (en) | Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof | |
Siemion et al. | Anti-IL-1 activity of peptide fragments of IL-1 family proteins |